Effect of Desflurane and propofol on immune cell population in breast cancer patients
Not Applicable
Completed
- Conditions
- Neoplasms
- Registration Number
- KCT0000939
- Lead Sponsor
- Ewha Womans University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
1) aged 18 to 85 years
2) ASA (American society of anesthesiology) class I-III
3) Womens scheduled for mastectomy, axillary node dissection or wide local tumor excision in Ewha womans university Mokdong hospital .
Exclusion Criteria
1) previous breast cancer surgery (except diagnostic biopsy)
2)inflammatory breast cancer, evidence of systemic infections (clinically defined or elevated C-reactive protein levels, leukocytosis, body temperature=37.8?)
3) any contraindication to midazolam, propofol, desflurane, fentanyl, rocuronium or nocuronium.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cytokine counts (IL-2/IL-4)
- Secondary Outcome Measures
Name Time Method lymphocyte, leukocyte